Too much to differentiate: aneuploidy promotes proliferation and teratoma formation in embryonic stem cells by Storchova, Z.
News & Views
Too much to differentiate: aneuploidy
promotes proliferation and teratoma
formation in embryonic stem cells
Zuzana Storchová1,2
Aneuploidy, or an uneven number of chro-
mosomes, has mostly detrimental conse-
quences in eukaryotic cells, which include
impaired proliferation as well as compro-
mised DNA replication and protein folding.
Unexpectedly, a new study published in
this issue of The EMBO Journal shows that
in murine embryonic stem cells aneuploidy
does not interfere with proliferation, but
rather hinders their differentiation capac-
ity, thus propelling the formation of poorly
differentiated teratomas.
See also: M Zhang et al (November 2016)
M aintaining genome integrity is anessential task for every cell andthere are many ways in which
things can go wrong. One of the most
frequent errors affecting genome integrity is
chromosome missegregation, which occurs
at an estimated frequency of 1:1,000 in
mitosis and even more often during meio-
sis. In the immediate response to chromo-
some segregation errors, most cells will
irreversibly arrest, but surviving cells can
give rise to an aneuploid population. Aneu-
ploidy, a cellular state characterized by an
unbalanced number of chromosomes, is
the leading cause of spontaneous miscar-
riages and a hallmark of cancer. Yet, what
makes aneuploidy so detrimental to cellular
physiology has been difficult to tackle.
Recent years have witnessed an increased
interest in aneuploidy fueled to a great
degree by the establishment of novel cell
models with simple defined aneuploidies.
Over the past years, model systems from
yeast, Drosophila, Arabidopsis as well as
murine and human somatic cells have been
established that gained a part or a whole
chromosome and their phenotypes and
physiology have been analyzed in comparison
with their isogenic euploid counterparts.
Most studies using these model systems
revealed that a gain of even a single chromo-
some impairs proliferation and leads to glob-
ally altered gene expression, proteotoxic
stress, elevated genomic instability, and dif-
ferential drug sensitivity (for a recent
review, see Santaguida and Amon, 2015).
While the underlying molecular mechanisms
of these complex changes remain poorly
understood, two striking features became
apparent: i) there is a marked similarity in
the cellular response to aneuploidy across
species regardless of the identity of the extra
chromosome, and ii) the findings fail to
provide a plausible explanation for whether
and how exactly aneuploidy per se promotes
cancer.
All the above-mentioned results were
obtained with somatic aneuploid cells. The
consequences of aneuploidy in stem cells,
which differ from somatic cells in many
aspects, have not been systematically inves-
tigated. In a study published in this issue of
The EMBO Journal, Meili Zhang and
coworkers characterized multiple aneuploid
cell lines derived from murine embryonic
stem cells. Using PiggyBac-based DNA
vectors that are both positively and nega-
tively selectable based on their copy
numbers, the authors were able to create a
series of murine embryonic stems cells
trisomic for chromosome 6, 8, 11, 12, or 15.
Thanks to the used selection cassette, these
cells can be easily corrected to diploidy,
which provides closely matched control cell
lines. Remarkably, four out of five trisomic
ES cell lines showed normal or higher prolif-
eration rates and formed more colonies then
diploid controls. These colonies expressed
alkaline phosphatase and pluripotency
markers, which demonstrates that they have
maintained their stemness. Moreover, spon-
taneous differentiation was delayed and
inefficient in trisomic cells and their lineage
commitment was impaired. Upon subcuta-
neous injection into immunodeficient SCID
mouse, trisomic cells created poorly dif-
ferentiated teratomas and teratocarcinomas
faster than diploids and displayed increased
tumor weight.
To determine the reasons for the differen-
tiation defects, the authors analyzed gene
expression and identified uniform global
transcriptional changes independent of the
type of the extra chromosome. The pattern
of gene expression changes was different to
what has previously been observed in
somatic aneuploids (e.g., Sheltzer, 2013;
Du¨rrbaum et al, 2014). The only pathways
that seem to be deregulated similarly in both
somatic and stem cells were related to extra-
cellular region and matrix, although dif-
ferent genes were affected in the different
cell types. In striking contrast to the aneu-
ploid somatic cells, no downregulation of
replication- and cell cycle-related pathways
was observed. This observation is in
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agreement with the absence of a prolifera-
tion defect in aneuploid ES cells in the
current study. Instead, several pathways
related to development were significantly
downregulated, among them neural plate
development, BMP signaling, Fgf receptor
signaling, and others linked in particular to
primed pluripotency and differentiation-
associated processes.
The authors hypothesized that the
increased tumorigenic potential of the trisomic
cells might be due to both the increased
proliferative potential combined with reduced
differentiation capacity. Interestingly, the
lack of differentiation in aneuploid cells was
not due to changes in DNA and histone
methylation status of aneuploid cells. Instead,
the impaired differentiation of trisomic cells
could be rescued by culturing in a mixture
with diploid ES cells or by the addition of
conditioned media. Consistently, addition of
extracellular differentiation factor BMP4 was
sufficient to partially complement the dif-
ferentiation defects of aneuploidy ES cells.
These findings support previous observa-
tions obtained with ES cell lines with
trisomy 21 that revealed in various settings
that chromosome gain interferes with dif-
ferentiation (e.g., Roy et al, 2012). Similarly,
spontaneously arising human stem cells
with trisomy of chromosome 12 (T12-hPSC)
grew faster in culture, showed increased
replication and gave rise to more aggressive
teratomas and teratocarcinomas from which
pluripotent cells could be recovered,
suggesting that the cells remained largely
undifferentiated (Ben-David et al, 2014). In
contrast, proliferation capacity was strongly
impaired in aneuploid murine hematopoietic
stem cells that were either trisomic for a
specific chromosome or chromosomally
unstable due to increased chromosome
missegregation rates caused by mutation in
spindle assembly checkpoint gene Bub1
(Pfau et al, 2016). Similar results were
obtained in Drosophila cells where aneu-
ploidy was induced by interference with
centrosome duplication and spindle assem-
bly checkpoint by overexpressing Sak (the
Plk4 ortholog) in combination with a dele-
tion of the spindle assembly checkpoint
protein Mad2 (Gogendeau et al, 2015). Here,
aneuploidy in neural stem cells and adult
intestinal stem cells reduces the number of
proliferative cells mainly due to an extended
G1 phase, which leads to cell cycle exit,
premature differentiation, and decreased
tumorigenic potential.
The results obtained in vitro using vari-
ous cell types and species demonstrate
convincingly that the cellular response to
aneuploidy is largely independent of the
type of aneuploidy and the identity of the
altered chromosomes. Instead, the response
is highly cell type specific and surprisingly
complex. While aneuploid somatic cells
and somatic stem cells experience a series
of detrimental consequences that impede
their proliferation and slow down tumor
formation (Gogendeau et al, 2015; Sheltzer
et al, 2016), embryonic stem cells appear to
proliferate well and promote tumor forma-
tion even with an extra chromosome (Fig 1).
These observations are reminiscent of those
obtained with in vivo mouse models devel-
oped to study the role of chromosomal
instability and aneuploidy in tumorigenesis
that revealed that aneuploidy may act both
as an oncogene and a tumor suppressor
(e.g., Weaver et al, 2007). The presented
work might provide new insight into
the conundrum of how aneuploidy can
promote carcinogenesis despite having
anti-proliferative effects in somatic cells. In
the future, it will be essential to understand
why the ES cells respond to aneuploidy so
differently.
Stem cells hold huge promise for regener-
ative medicine and serve as a model system
for studying diseases and developing new
drugs. While aneuploid cells seem to accu-
mulate in various somatic cell types in the
aging mouse, aneuploidy in stem cell
lineages in the same mice remains rare, indi-
cating that mechanisms protecting against
numerical chromosome abnormalities are
efficient in stem cells. Yet, due to so far
unknown reasons trisomies often arise spon-
taneously in in vitro stem cell cultures. This
frequent spontaneous aneuploidy represents
a substantial risk for future therapeutic
applications. Additional studies and novel
models of aneuploidy will therefore be
essential to better understand how aneu-
ploidy arises in in vitro stem cell cultures
and to elucidate the consequences for the
physiology and function of stem cells under
different conditions.



























Figure 1. Aneuploidy in embryonic stem cells results in increased proliferation and impaired
differentiation, a combination that promotes cancer.
As shown in the left, somatic cells display altered gene expression that negatively affects genes required for
cell cycle progression as well as proteotoxic stress and impaired protein folding in response to aneuploidy.
This response is conserved among species and usually leads to proliferative disadvantage and genomic
instability. Embryonic stem cells exert different gene expression changes that affect extracellular matrix and
developmental signaling upon gain of chromosome 6, 8, 11, 12 or 15, as shown by Zhang et al (2016). In
contrast to somatic cells, aneuploid ES cells maintain proliferative capacity and induce tumorigenesis
in vivo. ECM, extracellular matrix.
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